Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary...

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Oxidative Stress

Background:

• Mitochondrial dysfunction, including excess reactive oxygen species (ROS) and impaired ATP generation, is a key pathology in Alzheimer's disease (AD).
• Amyloid beta (Aβ) exacerbates mitochondrial dysfunction and neuronal injury by increasing ROS production and disrupting redox balance.

Purpose of the Study:

• To investigate the protective effects of mitotempo, a novel mitochondria-targeted antioxidant, against Aβ-induced mitochondrial toxicity in primary cultured neurons.
• To evaluate mitotempo's ability to preserve mitochondrial function and neuronal integrity in an Alzheimer's disease model.

Main Methods:

• Primary cultured neurons were treated with Aβ in the presence or absence of mitotempo.
• Assessed mitochondrial superoxide production, lipid oxidation, mitochondrial membrane potential, and ATP production.
• Measured cytochrome c oxidase activity, mitochondrial DNA (mtDNA) levels, and expression of mtDNA replication factors (DNA polymerase gamma and Twinkle).

Main Results:

• Mitotempo significantly suppressed Aβ-induced mitochondrial superoxide production and neuronal lipid oxidation.
• Mitotempo preserved mitochondrial bioenergetics, including membrane potential, cytochrome c oxidase activity, and ATP production.
• Mitotempo mitigated Aβ-induced mtDNA depletion and decreased expression of DNA polymerase gamma and Twinkle.

Conclusions:

• Eliminating excess mitochondrial ROS with mitotempo rescues mitochondrial function in Aβ-insulted neurons.
• Mitotempo demonstrates potential as a therapeutic agent for protecting mitochondrial and neuronal function in Alzheimer's disease.